Back to results
US 2024/0182540 A1Published application
Chimeric apoptotic signal targeting lymphocytes (tim-4 castl) and methods of making and using same
OwnerPeter Fecci, Daniel Wilkinson +1inventors
InventorsPeter Fecci, Daniel Wilkinson, Ethan Srinivasan
Life of this patent
Estimating the term…
Abstract
The present invention provides recombinant TIM-4 fusion proteins comprising an extracellular domain of TIM-4 and at least one co-stimulatory domain. Also provided are cells comprising the fusion protein and methods of making and using the same.
Claims24
A TIM-4 fusion protein comprising a TIM-4 extracellular domain and at least one co-stimulatory domain, wherein the TIM-4 extracellular domain comprises SEQ ID NO:
- 7 or a sequence having at least 95% identity to SEQ ID NO:
- 7.
The method 14, wherein the cancer is a PS-associated cancer.
Dependencies are inferred from the claim text.